Stock listing

T3X Stock Price, News, Filings & Events — Telix Pharmaceuticals Limited

Selected listing: T3X · DUS · EUR · DE

The T3X:DUS listing represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on the development of targeted therapies for cancer. The company is actively engaged in advancing its product pipeline, which includes innovative treatments utilizing radiopharmaceuticals. Recent news highlights their ongoing clinical trials and regulatory filings, reflecting their commitment to addressing unmet medical needs in oncology. Investors can stay informed about upcoming events and market developments that may impact Telix's growth and strategic direction.

T3X:DUSEURDEUpdated July 21, 2026
Telix Pharmaceuticals Limited logo
Ticker
T3X:DUS
Asset type
Stock
Market cap
$3.71B
Sector
Health Technology
Industry
Biotechnology
Exchange
DUS
Currency
EUR

Telix Pharmaceuticals Limited T3X:DUS stock context

The T3X:DUS listing represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on the development of targeted therapies for cancer. The company is actively engaged in advancing its product pipeline, which includes innovative treatments utilizing radiopharmaceuticals. Recent news highlights their ongoing clinical trials and regulatory filings, reflecting their commitment to addressing unmet medical needs in oncology. Investors can stay informed about upcoming events and market developments that may impact Telix's growth and strategic direction.

Research Telix Pharmaceuticals Limited

Alternate listings